Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Cash from Financing Activities (2020 - 2026)

Updated

Nuvalent (NUVL) reported Cash from Financing Activities of $9.8 million for Q1 2026, up 115.5% from $4.55 million a year earlier but down 98.0% from the prior quarter.

Analysis

Nuvalent (NUVL) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Over the twelve months ended Mar 31, 2026, Nuvalent's Cash from Financing Activities came in at $520.59 million, down 8.3% year-over-year; for FY2025, it came in at $515.34 million, down 9.4% from FY2024.

  • Cash from Financing Activities has a five-year compound annual growth rate of 87.5% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $568.88 million in FY2024 (+68.9%), $336.85 million in FY2023 (+35.3%), $248.92 million in FY2022 (-21.8%) and $318.22 million in FY2021.
  • Five-year quarterly Cash from Financing Activities spans a low of -$944,000 in Q4 2021 and a high of $550.27 million in Q3 2024.
  • Year over year, Cash from Financing Activities gained in three of the last six quarters, with growth averaging 25.5%.
  • The high point for year-over-year Cash from Financing Activities in five years was Q2 2024 (growth of 218.7%); the low point was Q2 2022 (a decline of 100.0%).
  • Per Business Quant data, the three quarters before Q1 2026 came in at $500.26 million (Q4 2025), $4.77 million (Q3 2025) and $5.76 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Nuvalent 9.75 Bn 9.75 Bn - 9.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 9.80 Mn
Dec 31, 2025 500.26 Mn
Sep 30, 2025 4.77 Mn
Jun 30, 2025 5.76 Mn
Mar 31, 2025 4.55 Mn
Dec 31, 2024 8.49 Mn
Sep 30, 2024 550.27 Mn
Jun 30, 2024 4.14 Mn
Mar 31, 2024 5.99 Mn
Dec 31, 2023 333.42 Mn
Sep 30, 2023 2.14 Mn
Jun 30, 2023 1.30 Mn
Mar 31, 2023 -17,000.00
Dec 31, 2022 248.67 Mn
Sep 30, 2022 1.01 Mn
Jun 30, 2022 5,000.00
Mar 31, 2022 -768,000.00
Dec 31, 2021 -944,000.00
Sep 30, 2021 174.93 Mn
Jun 30, 2021 134.23 Mn
API Access

Nuvalent Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NUVL&period=max&api_key=YOUR_API_KEY